Aarti Drugs Limited (NSE:AARTIDRUGS)
445.40
+9.15 (2.10%)
Sep 24, 2026, 11:10 AM IST
Aarti Drugs Employees
Aarti Drugs had 1,355 employees as of March 31, 2026. The number of employees increased by 71 or 5.53% compared to the previous year.
Employees
1,355
Change (1Y)
71
Growth (1Y)
5.53%
Revenue / Employee
19.76M INR
Profits / Employee
1.41M INR
Market Cap
39.82B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 1,355 | 71 | 5.53% |
| Mar 31, 2025 | 1,284 | 220 | 20.68% |
| Mar 31, 2024 | 1,064 | 61 | 6.08% |
| Mar 31, 2023 | 1,003 | -447 | -30.83% |
| Mar 31, 2022 | 1,450 | -170 | -10.49% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Indoco Remedies | 6,000 |
| Aarti Pharmalabs | 2,421 |
| Solara Active Pharma Sciences | 1,669 |
| Ind-Swift Laboratories | 1,388 |
| Windlas Biotech | 1,385 |
| RPG Life Sciences | 1,366 |
| Orchid Pharma | 1,169 |
| Beta Drugs | 455 |
Aarti Drugs News
- 7 weeks ago - Aarti Drugs Transcript: Q1 26/27 - Transcripts
- 7 weeks ago - Aarti Drugs Quarterly report: Q1 2027 - Filings
- 7 weeks ago - Aarti Drugs Slides: Q1 2027 - Filings
- 2 months ago - Pharma sector stocks today, July 7: Aarti Drugs jumps 1.84%, Zydus Life rises 1.16%, Divis Lab up 1.18% - Business Upturn
- 4 months ago - Pharma sector stocks today, May 26: Wockhardt rises 3.91%, Sudeep Pharma up 2.10%, Aarti Drugs gains 2.35% - Business Upturn
- 4 months ago - Pharma sector stocks today, May 19: Strides Pharma crashes 4.84%, J.B. Chemicals rises 2.09%, Aarti Drugs up 2.90% - Business Upturn
- 4 months ago - Pharma Stocks Today, May 19: Strides Pharma crashes 4.84%, J.B. Chemicals rises 2.09%, Aarti Drugs up 2.90% - Business Upturn
- 4 months ago - Aarti Drugs Transcript: Q4 25/26 - Transcripts